PA
BFST icon

PharVision Advisers’s Business First Bancshares BFST Stock Holding History

PharVision Advisers’s Portfolio BFST Stock Details BFST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-11,334
Closed -$296K – 157
2025
Q4 		$296K Buy
+11,334
New +$287K 0.15% 280

Other funds holding BFST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Manulife (Manufacturers Life Insurance)
Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $128B AUM 35.83% 1-Year Est. Return

PharVision Advisers's BFST Position: Q1 2026 in Review

PharVision Advisers sold out of Business First Bancshares (BFST) in Q1 2026, closing a stake of 11,334 shares — an estimated $296K sold.

PharVision Advisers first reported a position in BFST in Q4 2025 and held it in 1 quarter. The position peaked at $296K in Q4 2025. 170 funds tracked by Wall St. Rank hold BFST as of Q1 2026.

  • PharVision Advisers reported no remaining Business First Bancshares position as of Q1 2026 after selling out during the quarter.
  • PharVision Advisers sold 11,334 Business First Bancshares shares in Q1 2026, an estimated $296K.
  • PharVision Advisers first reported a position in Business First Bancshares in Q4 2025 and held it in 1 quarter.
  • PharVision Advisers's Business First Bancshares position peaked at $296K in Q4 2025.
  • 170 funds tracked by Wall St. Rank held Business First Bancshares as of Q1 2026.

Based on PharVision Advisers's 13F filing for Q1 2026, filed 22 Apr 2026.